Journal of Pharmacokinetics & Experimental Therapeutics
Open Access

Adalimumab Pharmacokinetics

Search results for
Adalimumab Pharmacokinetics

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Awards & Nominations
Publication Policies and Ethics
Google Scholar citation report
Citations : 14

Journal of Pharmacokinetics & Experimental Therapeutics received 14 citations as per Google Scholar report

Flyer image
Journal of Pharmacokinetics & Experimental Therapeutics peer review process verified at publons
Publon image
Indexed In
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • Publons
  • ICMJE
View More
Useful Links
Share This Page

Adalimumab Pharmacokinetics

Adalimumab is used to treat people with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, and children with juvenile idiopathic arthritis. Pharmacokinetic parameters were analyzed for adalimumab and MTX during both phases of the study.

Journals Related to Adalimumab Pharmacokinetics:

Journal of Pharmacokinetics & Experimental Therapeutics, International Journal of Drug Development and Research, Drug Metabolism & Toxicology, Journal of Pharmacokinetics and Biopharmaceutics, Journal of Pharmacokinetics and Pharmacodynamics, Asian Journal of Pharmacodynamics and Pharmacokinetics.

Adalimumab Pharmacokinetics

Expert PPTs

Speaker PPTs

Conference Proceedings